|
| News Groups Blog Forum Chat Video Audio Images Documents Wiki Home |
|
|||||||
| Register | Tags | FAQ n Rules | Mark Forums Read |
| Notices |
| Piperazines Piperazines and piperazine containing party products. |
![]() |
|
|
Thread Tools | Display Modes |
|
|
|
#2
|
||||
|
||||
|
Serotonin receptors and animal models of aggressive behavior.
Olivier B, Mos J, van Oorschot R, Hen R. CNS-Pharmacology, Solvay Duphar B.V., Weesp, The Netherlands. Various models of rodent agonistic behavior are described, which differentiate between offensive and defensive/flight models. Particular attention is given to one male and one female paradigm for offensive aggression, i.e. resident/intruder or territorial aggression (RI) and maternal aggression (MA). After an overview of the serotonin (5-HT) system in the CNS, a description is given of the ligands available. Subsequently, the effects of various drugs affecting serotonergic transmission in the RI- and MA-paradigms are described. The 5-HT1A receptor agonists busipirone, ipsapirone, and 8-OH-DPAT decreased aggression in RI and MA, but simultaneously led to a marked decrease in social interest and activity, indicative of a nonspecific antiaggressive profile. Nonselective 5-HT1 receptor agonists, such as RU24969, eltoprazine, and TFMPP reduced aggression quite specifically, did not decrease social interest or exploration, and sometimes even increased these behaviors. In RI and MA, the behavioral effects of these drugs were roughly similar. In contrast, MA was more sensitive to treatment with the 5-HT reuptake blocker fluvoxamine, which blocked RI aggression nonspecifically at the highest dose only. DOI, a 5-HT2A/2C# receptor agonist, decreased aggressive behavior and increased inactivity, without affecting social interest and exploration in RI as well as MA. This was, however, accompanied by "wet dog shaking" characteristic of 5-HT2 receptor stimulation. The nonspecific 5-HT receptor agonist (and 5-HT2 receptor antagonist) quipazine also induced "wet dog shaking" at doses which suppressed aggression, social interest, and exploration but increased inactive behaviors (sitting and lying). The discussion delineates a specific role for 5-HT1B receptor-subtype involvement in the modulation of aggression, with the restrictions we clearly face with regard to the lack of specific serotonergic agonists and antagonists for certain receptor subtypes. By and large, male and female rats react similarly to treatment with serotonergic drugs, and this fact underlines the consistent role of 5-HT in different forms of aggression. Edited by: Alfa |
|
#3
|
||||||||||||
|
||||||||||||
|
From several generations past, SWIMs lab rats found this substance very
toxic. Non-specific MDA like high without a whole lot of euphoria and threshold visuals. Some nausea at come up, and electric sensations which slowly increased in intensity, ultimately to evolve into stabbing pains in SWIM's labrat's heads. Poor rats though they were gonna die, but survived with a hangover and probably some brain damage. Dose as swim recalls was 100mg with 100 mg BZP. BZP was never a problem on its own (if fact, the rats liked it..), but this stuff is nasty ! Note many at the time really liked it, but SWIMs rats were not the only ones to complain. No loss for the Japanese IMHO. Snapper |
|
#4
|
|||||||||||
|
|||||||||||
|
i was wondering about the bzp/TFMPP combo too. there seems to be some really good reports of mdma like buzz going on but a # of reports are negative & mention an overall toxic feeling. i'm wondering if maybe the dosing is too high and if smaller doses would be free of side efx
|
|
#5
|
||||
|
||||
|
That's a different topic.
TFMPP When combined with BZP has mild hallucinogenic effect simular to ecstasy (MDMA), but does not have the emotional (empathic) effects of ecstasy. TFMPP affects the dopamine and noradraline system, like BZP, but more significantly the serotonin system. Effects:
|
![]() |
| Bookmarks |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Piperazine Basics | Euphoric | Piperazines | 21 | 06-08-2009 16:30 |
| New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine (2003) | Jatelka | Drug testing | 1 | 01-03-2008 20:18 |
| Sitelinks: | Site Functions: |